M&T Bank
CTIC

M&T Bank’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

M&T Bank’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,446
Closed -$28K – 2204
2015
Q2 		$28K Buy
+1,446
New +$27.9K ﹤0.01% 1976
2014
Q4 		– Sell
-1,407
Closed -$34K – 2370
2014
Q3 		$34K Buy
+1,407
New +$36.6K ﹤0.01% 2118

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

M&T Bank's CTIC Position: Q3 2015 in Review

M&T Bank sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2015, closing a stake of 1,446 shares — an estimated $28K sold.

M&T Bank first reported a position in CTIC in Q3 2014 and held it in 2 quarters. The position peaked at $34K in Q3 2014. 86 funds tracked by Wall St. Rank hold CTIC as of Q3 2015.

  • M&T Bank reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2015 after selling out during the quarter.
  • M&T Bank sold 1,446 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2015, an estimated $28K.
  • M&T Bank first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2014 and held it in 2 quarters.
  • M&T Bank's CTI BioPharma Corp. (DE) Common Stock position peaked at $34K in Q3 2014.
  • 86 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.